Gemfibrozil v placebo for secondary prevention of coronary artery disease (CAD) in men with low levels of high density lipoprotein cholesterol‡
| Outcomes at 5 y | Gemfibrozil | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| ‡Abbreviations defined in glossary; NNT and CI provided by author. | ||||
| Non-fatal myocardial infarction or CAD death | 17.3% | 21.7% | 22% (7 to 35) | 23 (13 to 74) |
| Stroke | 5.1% | 6.9% | 29% (2 to 48) | 56 (27 to 725) |